[HTML][HTML] Review of the assessment and management of neonatal abstinence syndrome
SM Bagley, EM Wachman, E Holland… - Addiction science & …, 2014 - Springer
Neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure is an
increasing problem. Variability in assessment and treatment of NAS has been attributed to …
increasing problem. Variability in assessment and treatment of NAS has been attributed to …
Prescription opioids in pregnancy and birth outcomes: a review of the literature
Prescription opioids are used prenatally for the management of pain, as well as for opiate
dependency. Opioids are known to cross the placenta and despite the evidence of possible …
dependency. Opioids are known to cross the placenta and despite the evidence of possible …
Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis
SB Brogly, KA Saia, AY Walley, HM Du… - American journal of …, 2014 - academic.oup.com
Increasing rates of maternal opioid use during pregnancy and neonatal withdrawal, termed
neonatal abstinence syndrome (NAS), are public health concerns. Prenatal buprenorphine …
neonatal abstinence syndrome (NAS), are public health concerns. Prenatal buprenorphine …
Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada
DT Wijeratne, K Lajkosz, SB Brogly… - … Quality and Outcomes, 2018 - Am Heart Assoc
Background: The World Health Organization recognizes 5 groups of pulmonary
hypertension (PH), categorized by pathogenesis or comorbidity: 1-pulmonary arterial …
hypertension (PH), categorized by pathogenesis or comorbidity: 1-pulmonary arterial …
[HTML][HTML] Epidemiology and management of thoracic aortic dissections and thoracic aortic aneurysms in Ontario, Canada: a population-based study
RS McClure, SB Brogly, K Lajkosz, D Payne… - The Journal of thoracic …, 2018 - Elsevier
Objectives To determine hospital incidence, mortality, and management for thoracic aortic
dissections and aneurysms. Methods A population-based retrospective cohort study of …
dissections and aneurysms. Methods A population-based retrospective cohort study of …
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children
SB Brogly, N Ylitalo, LM Mofenson, J Oleske… - Aids, 2007 - journals.lww.com
Background: There is equivocal evidence of in utero nucleoside reverse transcriptase
inhibitor (NRTI) exposure and the occurrence of mitochondrial dysfunction (MD) in HIV …
inhibitor (NRTI) exposure and the occurrence of mitochondrial dysfunction (MD) in HIV …
Prenatal protease inhibitor use and risk of peterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy
K Patel, DE Shapiro, SB Brogly… - The Journal of …, 2010 - academic.oup.com
Background. Conflicting results have been reported among studies of protease inhibitor (PI)
use during pregnancy and preterm birth. Uncontrolled confounding by indication may …
use during pregnancy and preterm birth. Uncontrolled confounding by indication may …
Reproductive health of adolescent girls perinatally infected with HIV
SB Brogly, DH Watts, N Ylitalo… - … Journal of Public …, 2007 - ajph.aphapublications.org
Objectives. We sought to describe the reproductive health of adolescent girls perinatally
infected with HIV. Methods. We estimated the incidence of first pregnancy, genital infections …
infected with HIV. Methods. We estimated the incidence of first pregnancy, genital infections …
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C
SB Brogly, MJ Abzug, DH Watts… - The Pediatric …, 2010 - journals.lww.com
Background: Some studies have detected associations between in utero antiretroviral
therapy (ARV) exposure and birth defects but evidence is inconclusive. Methods: A total of …
therapy (ARV) exposure and birth defects but evidence is inconclusive. Methods: A total of …
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals
KM Knapp, SB Brogly, DG Muenz… - The Pediatric …, 2012 - journals.lww.com
Background: Although use of efficacious interventions, including antiretrovirals (ARVs), has
dramatically reduced the rate of mother-to-child transmission of human immunodeficiency …
dramatically reduced the rate of mother-to-child transmission of human immunodeficiency …